Wyeth sues FDA to block rival generic antibiotic

Wednesday, September 23, 2009 - 09:14 in Health & Medicine

MADISON, N.J. (AP) -- Drugmaker Wyeth is suing the Food and Drug Administration to block the sale of a generic rival to its intravenous antibiotic Zosyn, claiming the generic is not an equivalent product and could harm critically ill patients....

Read the whole article on

More from

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net